Total number of publications: 56
2026
-
Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin
Cancer Cell International, year: 2026, volume: 26, edition: 1, DOI
-
Data-Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Mass Spectrometry Reviews, year: 2026, DOI
2025
-
Catechol-O-methyltransferase detoxifies catechol estrogens but also plays a pro-metastatic role in triple negative breast cancer cells
Year: 2025, type: Conference abstract
-
Cell adhesion and EMT markers as downstream effectors of CKB signaling in metastatic process
Year: 2025, type: Conference abstract
-
DIA-MS identified transmembrane glycoprotein GPNMB as a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Year: 2025, type: Conference abstract
-
Global Interactome Mapping Reveals Protumorigenic Interactions of NF-κB in Breast Cancer
Year: 2025, type: Conference abstract
-
Integrated multiomics classification of triple negative breast cancer
Year: 2025, type: Conference abstract
-
Integrated proteogenomic analysis identifies synuclein gamma as a key target of the mesenchymal stem-like subtype of triple negative breast cancer
Year: 2025, type: Conference abstract
-
LC-MS/MS-based terminomics unravels carboxypeptidase B1 role in luminal A breast tumor progression
Year: 2025, type: Conference abstract
-
LC-MS/MS-based terminomics unravels role of carboxypeptidase B1 in luminal A breast cancer
Year: 2025, type: Conference abstract